175 related articles for article (PubMed ID: 11825950)
41. Performance evaluation of four type-specific commercial assays for detection of herpes simplex virus type 1 antibodies in a Middle East and North Africa population.
Aldisi RS; Elsidiq MS; Dargham SR; Sahara AS; Al-Absi ES; Nofal MY; Mohammed LI; Abu-Raddad LJ; Nasrallah GK
J Clin Virol; 2018 Jun; 103():1-7. PubMed ID: 29597097
[TBL] [Abstract][Full Text] [Related]
42. Whole cell lysate enzyme immunoassays vs. recombinant glycoprotein G2-based immunoassays for HSV-2 seroprevalence studies.
García-Corbeira P; Hogrefe W; Aguilar L; García-de-Lomas J; Gil A; Bayas JM; Vilella A; Dal-Ré R
J Med Virol; 1999 Dec; 59(4):502-6. PubMed ID: 10534733
[TBL] [Abstract][Full Text] [Related]
43. Herpes simplex virus type 2 in Brazil: seroepidemiologic survey.
Da Rosa-Santos OL; Gonçalves Da Silva A; Pereira AC
Int J Dermatol; 1996 Nov; 35(11):794-6. PubMed ID: 8915732
[TBL] [Abstract][Full Text] [Related]
44. Herpes simplex virus type 2 (HSV-2) IgG index values in two immunoassays in relation to HSV-2 IgG inhibition assay results.
Prince HE; Batterman HJ; Schwab DA
Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114864. PubMed ID: 31395403
[TBL] [Abstract][Full Text] [Related]
45. Recombinant glycoprotein G analog for determination of specific immunoglobulins to herpes simplex virus type 2 by ELISA.
Korshun L; Vudmaska M; Moysa L; Kovtonjuk G; Mikhalap S; Ganova L; Spivak N
J Virol Methods; 2013 Dec; 194(1-2):67-73. PubMed ID: 23933396
[TBL] [Abstract][Full Text] [Related]
46. Comparison of commercial methods of immunoblot, ELISA, and chemiluminescent immunoassay for detecting type-specific herpes simplex viruses-1 and -2 IgG.
de Ory F; Guisasola ME; Balfagón P; Sanz JC
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28332725
[TBL] [Abstract][Full Text] [Related]
47. Comparative performance of herpes simplex virus type 2-specific serologic assays from Meridian Diagnostics and MRL diagnostics.
Ribes JA; Hayes M; Smith A; Winters JL; Baker DJ
J Clin Microbiol; 2001 Oct; 39(10):3740-2. PubMed ID: 11574606
[TBL] [Abstract][Full Text] [Related]
48. Secreted portion of glycoprotein g of herpes simplex virus type 2 is a novel antigen for type-discriminating serology.
Görander S; Svennerholm B; Liljeqvist JA
J Clin Microbiol; 2003 Aug; 41(8):3681-6. PubMed ID: 12904375
[TBL] [Abstract][Full Text] [Related]
49. [Type-specificity of serum antibodies from genital herpes patients as determined by an enzyme-linked immunosorbent assay using HSV-infected cells as antigens].
Hashido M; Inouye S; Kawana T
Kansenshogaku Zasshi; 1995 Jul; 69(7):785-9. PubMed ID: 7561249
[TBL] [Abstract][Full Text] [Related]
50. Plasma versus serum for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies with a glycoprotein G2-based enzyme immunoassay.
Cherpes TL; Meyn LA; Hillier SL
J Clin Microbiol; 2003 Jun; 41(6):2758-9. PubMed ID: 12791924
[TBL] [Abstract][Full Text] [Related]
51. Premarket evaluation of the POCkit HSV-2 type-specific serologic test in culture-documented cases of genital herpes simplex virus type 2 [see comment].
Ashley RL; Wald A; Eagleton M
Sex Transm Dis; 2000 May; 27(5):266-9. PubMed ID: 10821598
[TBL] [Abstract][Full Text] [Related]
52. Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment.
Patel EU; Manucci J; Kahle EM; Lingappa JR; Morrow RA; Piwowar-Manning E; James A; Maluzi KF; Cheeba MM; Gray G; Kosloff B; Delany-Moretlwe S; Inambao M; Vwalika B; Quinn TC; Laeyendecker O
BMC Infect Dis; 2015 Sep; 15():398. PubMed ID: 26423888
[TBL] [Abstract][Full Text] [Related]
53. Herpes serology for dermatologists.
Goldman BD
Arch Dermatol; 2000 Sep; 136(9):1158-61. PubMed ID: 10987876
[TBL] [Abstract][Full Text] [Related]
54. Performance of the HerpeSelect (Focus) and Kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinicovirological reference standards in Brazil.
Nascimento MC; Ferreira S; Sabino E; Hamilton I; Parry J; Pannuti CS; Mayaud P
J Clin Microbiol; 2007 Jul; 45(7):2309-11. PubMed ID: 17507516
[TBL] [Abstract][Full Text] [Related]
55. Characterization of Serum Samples With Discordant Results in 2 Herpes Simplex Virus Type 2 IgG Assays.
Prince HE; Batterman HJ; Marlowe EM
Sex Transm Dis; 2022 May; 49(5):353-359. PubMed ID: 35067597
[TBL] [Abstract][Full Text] [Related]
56. Role of type-specific herpes simplex virus-1 and 2 serology as a diagnostic modality in patients with clinically suspected genital herpes: A comparative study in Indian population from a tertiary care hospital.
Patwardhan V; Bhalla P
Indian J Pathol Microbiol; 2016; 59(3):318-21. PubMed ID: 27510668
[TBL] [Abstract][Full Text] [Related]
57. Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.
Wales SQ; Smith CC; Wachsman M; Calton G; Aurelian L
Clin Diagn Lab Immunol; 2004 Jan; 11(1):42-9. PubMed ID: 14715543
[TBL] [Abstract][Full Text] [Related]
58. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.
Ashley RL; Militoni J; Lee F; Nahmias A; Corey L
J Clin Microbiol; 1988 Apr; 26(4):662-7. PubMed ID: 2835389
[TBL] [Abstract][Full Text] [Related]
59. Seroprevalence of herpes simplex virus types 1 and 2 in HIV-infected and uninfected homosexual men in a primary care setting.
Russell DB; Tabrizi SN; Russell JM; Garland SM
J Clin Virol; 2001 Oct; 22(3):305-13. PubMed ID: 11564596
[TBL] [Abstract][Full Text] [Related]
60. Development of a time-resolved fluorescence immunoassay for herpes simplex virus type 1 and type 2 IgG antibodies.
Liang QN; Zhou JW; Liu TC; Lin GF; Dong ZN; Chen ZH; Chen JJ; Wu YS
Luminescence; 2015 Aug; 30(5):649-54. PubMed ID: 25377426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
